Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Arzneimittel-Forschung|January 1, 1987
Bioavailability of bi- and trivalent oral iron preparations. Investigations of iron absorption by postabsorption serum iron concentrations curvesH DietzfelbingerMMW, Munchener Medizinische Wochenschrift|February 6, 1981
[Therapy with blood components (author's transl)]F Woitinas, H DietzfelbingerMedizinische Klinik|April 15, 1977
[Investigations of the bioavailability of iron from bi- and trivalent iron salts (author's transl)]H Dietzfelbinger, W KabothMedizinische Klinik|November 30, 1979
[Comparison of bio-availability, antianaemic efficacy, tolerance and drug costs in oral iron(II) and iron(III) preparations (author's transl)]H Dietzfelbinger, W KabothMedizinische Klinik (Praxis-Ausg.)|May 7, 1982
[Clinical course of hairy cell leukemias]W Kaboth, H Theml, H DietzfelbingerLeukemia|July 2, 2004
An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosineU Jehn, R Bartl, H Dietzfelbinger, et al.Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1980
[Hematomorphological differential diagnosis of small cell lymphoma. What is the atypical chronic lymphadenosis?]H Theml, H Dietzfelbinger, A Burger-Schüler, et al.Annals of Hematology|April 22, 1999
Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosineU Jehn, R Bartl, H Dietzfelbinger, et al.Investigational New Drugs|January 1, 1996
Clinical phase I and pharmacokinetic trial of the new titanium complex budotitaneT Schilling, K B Keppler, M E Heim, et al.Medizinische Klinik|June 10, 1977
[Clinical observations to characterize splenomegalic immunocytomas (author's transl)]H Theml, A Burger, E Keiditsch, et al.Pageof 2